Ohio Sleep Medicine Institute

Dublin, Ohio 43107

2 studies enrolling now · 28 studies all time

What they study most

Cataplexy, Cataplexy Narcolepsy, Central Sleep Apnea, Dysthymic Disorder, Excessive Daytime Sleepiness, Excessive Daytime Somnolence, Healthy Volunteers, Idiopathic Hypersomnia, Insomnia, Major Depressive Disorder, Narcolepsy, Narcolepsy Type 1

Studies at this site

• A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions — Recruiting now
• Child and Adolescent Registry for Participants With Narcolepsy — Recruiting now
• Study of SDX in Patients With Idiopathic Hypersomnia (IH) — Completed
• Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM) — Running, not enrolling
• Observational Study of LUMRYZ in Narcolepsy — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• An Open Label Study of FT218 in Subjects With Narcolepsy — Completed
• remedē System Therapy Study — Running, not enrolling
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 1 — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 2 — Completed
• Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) — Completed
• Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study) — Completed
• Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS — Completed
• Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction — Completed
• An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy — Completed
• An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy — Completed
• eXciteOSA for Treatment of Moderate Obstructive Sleep Apnea — Completed
• eXciteOSA for Treatment of Mild Obstructive Sleep Apnea — Status unconfirmed
• Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy — Completed
• Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization in Patients With an Inspire Upper Airway Stimulation System (Comparison of Home Sleep Testing vs. In-lab Polysomnography Testing) — Completed
• Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy — Completed
• The Evaluation of the Toffee Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea — Completed
• Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants — Completed
• Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea — Withdrawn before enrolling
• Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy — NO_LONGER_AVAILABLE
• Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) — Completed
• Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression — Completed